Showing 761 - 780 results of 9,939 for search '"immunization"', query time: 0.22s Refine Results
  1. 761
  2. 762

    Urban Immunity Against the Pandemic within the Framework of Public Administration, City and Citizens by Nilüfer Negiz, Pınar Savaş-Yavuzçehre

    Published 2021-05-01
    Subjects: “…urban immunity, immunized city, pandemic, Covid-19, local government, central government…”
    Get full text
    Article
  3. 763
  4. 764
  5. 765

    Th9 Cells in Peripheral Blood Increased in Patients with Immune-Related Pancytopenia by Qing Shao, Yangyang Wang, Zhaoyun Liu, Hui Liu, Yihao Wang, Yang Zhao, Lijuan Li, Rong Fu

    Published 2020-01-01
    “…Background. Immune-related pancytopenia (IRP) is a kind of autoimmune disease mediated by autoantibodies in bone marrow. …”
    Get full text
    Article
  6. 766
  7. 767

    Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins by Anna-Sophia Hartke, Cara S. Schreiber, Kristina Lau, Ivo Wiesweg, Inken Waltl, Ulrich Kalinke, Franziska Richter, Christopher Käufer

    Published 2025-02-01
    “…Clinical parameters, flow cytometry of blood and immune cells in the brain, brain immunohistology and motor behavior were evaluated over time. …”
    Get full text
    Article
  8. 768

    Harnessing Tumor Cell‐Derived Exosomes for Immune Rejection Management in Corneal Transplantation by Jieru Yang, Huanmin Kang, Yingyi Liu, Shan Lu, Huihui Wu, Bikui Zhang, Yan He, Wenhu Zhou

    Published 2025-01-01
    “…Abstract Transplantation remains the definitive treatment for end‐stage organ failures, but its efficacy is frequently compromised by immune rejection. This study introduces a novel strategy by utilizing tumor‐derived exosomes from B16‐F10 melanoma cells (B16‐Exo), diverging from the conventional use of immune cell‐derived exosomes, to alleviate post‐transplantation immune rejection. …”
    Get full text
    Article
  9. 769

    Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival by Gil-Ran Kim, Kyung-Ho Nam, Je-Min Choi

    Published 2024-12-01
    “…This review reevaluates the limitations of belatacept in achieving long-term acceptance of transplants and highlights the importance of regulatory T (Treg) cells in maintaining immune tolerance and preventing graft rejection. Additionally, it discusses the potential benefits of combining therapies that boost Treg cells with belatacept to increase the effectiveness of immunosuppression and improve graft outcomes.…”
    Get full text
    Article
  10. 770
  11. 771
  12. 772
  13. 773

    Noise immunity of active vibro-acoustic method of monitoring the state of the main pipeline by A. A. Fedotov, R. A. Ahmedzhanov

    Published 2018-04-01
    “…Improving noise immunity is one of the main tasks in developing methods and systems of vibro-acoustic control. …”
    Get full text
    Article
  14. 774

    Stability Analysis of an In-Host Viral Model with Cure of Infected Cells and Humoral Immunity by Hui Wang, Rong Wang, Zhixing Hu, Fucheng Liao

    Published 2013-01-01
    “…An in-host viral model with cure of infected cells and humoral immunity is studied. We prove that the stability is completely determined by the basic reproductive number R0 and show that the infection-free equilibrium E0 is globally asymptotically stable if and only if R0≤1. …”
    Get full text
    Article
  15. 775

    Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella by Dinh-Huy Nguyen, Sung-Hwan You, Hien Thi-Thu Ngo, Khuynh Van Nguyen, Khang Vuong Tran, Tan-Huy Chu, So-young Kim, Sang-Jun Ha, Yeongjin Hong, Jung-Joon Min

    Published 2024-08-01
    “…Here, we show that SAM-FC induces functional reprogramming of the tumor immune microenvironment by activating both the innate and adaptive arms of the immune system and can be used for targeted delivery of multiple immunotherapeutic payloads for the establishment of potent and long-lasting antitumor immunity.…”
    Get full text
    Article
  16. 776

    Acknowledging and addressing real-world challenges to treating immune-related adverse events by Bonnie L Bermas, Mitchell S von Itzstein, David E Gerber, Alexa Meara

    Published 2024-07-01
    “…Immune checkpoint inhibitors (ICIs) have revolutionized oncology treatment. …”
    Get full text
    Article
  17. 777
  18. 778
  19. 779
  20. 780

    Immune complex induced arthritis in rats: role of lipid mediators on cell infiltration by F. A. C. Rocha, L. E. C. Andrade, S. Jancar

    Published 1996-01-01
    “…We investigated the participation of lipid mediators in an experimental immune complex (IC) arthritis model in rats. The animals were subjected to intraarticular injection of anti-bovine sertLm albumin (BSA) IgG antibodies followed by i.v. injection of BSA. …”
    Get full text
    Article